Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Dermatology/Plastic Surgery
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Medicis Pharmaceutical
Approval Status: Approved January 1998
Treatment Area: ultraviolet-induced skin discolorations
Lustra has been approved for the treatment of
ultraviolet-induced skin discolorations and hyperpigmentation
associated with pregnancy, superficial trauma and the use of oral
contraceptives and hormone replacement therapy.
In clinical studies, Lustra demonstrated substantial reduction
in pigmented lesions in a two-week period, and the reservoir effect
of Lustra reduced damage from ultraviolet radiation versus
placebo.
Lustra contains 4% hydroquinone in a vehicle containing glycolic
acid and an antioxidant complex.
